Rajasthan Drug Official Under Probe for Misreporting Spurious Medicines Parthika Patel30 Sept 2025 3:16 PM ISTJaipur: A senior official from Rajasthan's Food Safety and Drug Control Commissionerate (FSDCC) is under investigation for allegedly misreporting...
Intas Pharma Told to Narrow Margins, Extend Duration in Pembrolizumab Trial Protocol Farhat Nasim30 Sept 2025 3:09 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has directed Intas Pharmaceuticals Ltd. to...
AbbVie to Launch Ovarian Cancer Drug ELAHERE in UK at US Price Levels Parthika Patel30 Sept 2025 2:57 PM ISTNew Delhi: AbbVie has announced that it will launch its ovarian cancer drug ELAHERE (mirvetuximab soravtansine-gynx) in the United Kingdom at a list...
Kala Bio Halts Eye Drug Development After Phase 2b Trial Failure Parthika Patel30 Sept 2025 2:49 PM ISTNew Delhi: KALA BIO, Inc. a clinical-stage biopharmaceutical company focused on eye diseases, announced that its CHASE Phase 2b trial for KPI-012 in...
Novartis commences tender offer to buy Tourmaline Bio Ruchika Sharma30 Sept 2025 2:47 PM ISTBasel: Novartis has announced that Torino Merger Sub Inc., a Delaware corporation and an indirect wholly owned subsidiary of Novartis, has...
AstraZeneca to harmonise its listing structure across LSE, STO and NYSE Ruchika Sharma30 Sept 2025 12:00 PM ISTCambridge: AstraZeneca plans to harmonise its share listing structure to deliver a global listing for global investors in a global company. The...
JnJ Tremfya gets USFDA nod for pediatric plaque psoriasis, active psoriatic arthritis Ruchika Sharma30 Sept 2025 11:03 AM ISTHorsham: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved TREMFYA (guselkumab) for the treatment...
Amgen announces USD 650 million expansion of US manufacturing network Ruchika Sharma30 Sept 2025 10:00 AM ISTThousand Oaks: Amgen has announced a USD 650 million expansion of its U.S. manufacturing network, creating hundreds of new...
Zydus Lifesciences Slapped Rs 3.35 Crore Tax Demand Over CENVAT Credit Parthika Patel29 Sept 2025 10:48 PM ISTNew Delhi: Zydus Lifesciences Limited has informed the stock exchanges that the Commissioner of Central Goods and Services Tax (CGST), Ahmedabad, has...
Surat Businessman Arrested in Rs 8.5 Crore Pharma Fraud, Probe on Accomplices Parthika Patel29 Sept 2025 10:34 PM ISTAhmedabad: A massive Rs 8.5 crore fraud involving pharmaceutical raw materials has come to light, with Surat-based businessman Vikas Sharma accused of...
Relief Sought for Small Retailers as GST 2.0 Sparks Losses in Pharma Trade Susmita Roy29 Sept 2025 10:04 PM ISTNew Delhi: Noting the fact that the reduction in GST rates (18% to 5%, 12% to 0%, 12% to 5%) has benefited consumers, but it has severely impacted the...
MSN Lab gets CDSCO panel nod for Phase IV CT of Tofacitinib Oral Solution Susmita Roy29 Sept 2025 9:56 PM ISTNew Delhi: The Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control Organisation (CDSCO) has granted approval to MSN...
